Overview
The program will:
- Review the present-day rationale for neoadjuvant systemic therapy of early-stage non-small cell lung cancer;
- Assess data from the most recent neoadjuvant clinical trials;
- Identify and discuss recent developments in the integration of immunotherapy in neoadjuvant approaches.
- Examine the expanding neoadjuvant clinical trials landscape.
Following the presentation, there will be ample time for discussion and a question/answer session. Attendees will be able to submit questions and comments to Dr. Forde and Dr. Govindan via internet chat.
Patrick Forde, M.B.B.Ch
Assistant Professor of Oncology, Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins, Baltimore, Maryland.
Program Chair-Ramaswamy Govindan, MD
Director, Section of Medical Oncology, Professor of Medicine, Anheuser-Busch Endowed Chair in Medical Oncology, Director, Section of Oncology, Washington University School of Medicine.
For any inquiries, please contact meetings@iaslc.org.
Patrick Forde, M.B.B.Ch
Assistant Professor of Oncology, Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins, Baltimore, Maryland.
Program Chair-Ramaswamy Govindan, MD
Director, Section of Medical Oncology, Professor of Medicine, Anheuser-Busch Endowed Chair in Medical Oncology, Director, Section of Oncology, Washington University School of Medicine.
For any inquiries, please contact meetings@iaslc.org.